Provided by Tiger Trade Technology Pte. Ltd.

BridgeBio Oncology Therapeutics, Inc

1.81
-0.0500-2.69%
Post-market: 1.810.00000.00%17:33 EST
Volume:450.96K
Turnover:826.74K
Market Cap:144.78M
PE:-0.85
High:1.94
Open:1.87
Low:1.79
Close:1.86
52wk High:14.87
52wk Low:1.79
Shares:79.99M
Float Shares:40.77M
Volume Ratio:0.81
T/O Rate:1.11%
Dividend:- -
Dividend Rate:- -
EPS(TTM):-2.1380
EPS(LYR):-4.3039
ROE:-46.35%
ROA:-28.17%
PB:0.49
PE(LYR):-0.42

Loading ...

BridgeBio Oncology Therapeutics President and CEO Pedro Beltran Sells $3,442.67 in Common Shares

Reuters
·
Yesterday

BridgeBio Oncology Therapeutics (BBOT) Receives a Buy from J.P. Morgan

TIPRANKS
·
Nov 18

BridgeBio Oncology Therapeutics Principal Accounting Officer Marc Cobo Reports Sale of Common Shares Worth $184.86

Reuters
·
Nov 18

BridgeBio Oncology Therapeutics Inc : JP Morgan Cuts Target Price to $17 from $23

THOMSON REUTERS
·
Nov 12

Analysts Offer Insights on Healthcare Companies: Alto Neuroscience, Inc. (ANRO), Humacyte (HUMA) and BridgeBio Oncology Therapeutics (BBOT)

TIPRANKS
·
Nov 12

These Analysts Cut Their Forecasts On BridgeBio Oncology After Q3 Results

Benzinga Earnings
·
Nov 12

BridgeBio Oncology Therapeutics (BBOT) Receives a Buy from Stifel Nicolaus

TIPRANKS
·
Nov 11

BridgeBio Oncology price target lowered to $15 from $21 at Piper Sandler

TIPRANKS
·
Nov 11

US Research Roundup-Abbvie, TransDigm Group, Visa

Reuters
·
Nov 11

BridgeBio Oncology Therapeutics Inc Reports Results for the Quarter Ended September 30 - Earnings Summary

Reuters
·
Nov 11

BridgeBio Oncology Therapeutics Q3 2026 Net Loss Narrows 24% to $34.2 Million

Reuters
·
Nov 11

BridgeBio Oncology Q3 EPS $(0.43) Beats $(0.69) Estimate

Benzinga Earnings
·
Nov 11

Bbot Reports Third Quarter 2026 Financial Results and Update on Corporate Progress

THOMSON REUTERS
·
Nov 11

Press Release: BBOT Reports Third Quarter 2026 Financial Results and Update on Corporate Progress

Dow Jones
·
Nov 11

BridgeBio Oncology Thera Price Target Cut to $13.00/Share from $18.00 by Morgan Stanley

Dow Jones
·
Oct 22

US Research Roundup-Axon Enterprise, Williams-Sonoma, Xcel Energy

Reuters
·
Oct 20

Bridgebio Oncology Therapeutics Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)

Reuters
·
Oct 13

JPMorgan cuts BridgeBio target, sees buying opportunity on selloff

TIPRANKS
·
Sep 11

U.S. Research Roundup-Caseys General Stores, Targa Resources, United Rentals

Reuters
·
Sep 10

BridgeBio Oncology Therapeutics (BBOT) Receives a Buy from Wedbush

TIPRANKS
·
Sep 09